The centerpiece of the event was a panel discussion among five luminaries of the aging field:
Laura Deming, founder of Longevity Fund and Age1
Simon Melov, professor at the Buck Institute for Research on Aging
Aydin Senkut, founder and managing partner of Felicis Ventures
Kristen Fortney, founder and CEO of BIOAGE
Sonia Arrison (moderator), author of “100 Plus: How the Coming Age of Longevity Will Change Everything”
Part 2 of a series of articles covering Unity Biotechnology’s inaugural R&D Day, a special presentation to investors and analysts highlighting the company’s recent progress and future plans.